The Lophos Story
Founded in 2021, Lophos Pharmaceuticals is focused on advancing the cultivation, commercialization, and scientific understanding of Peyote (Lophophora williamsii) and its naturally occurring alkaloids, including Mescaline.
We believe Peyote occupies a unique position at the intersection of culture, conservation, and future healthcare.
We are working to expand access to sustainably cultivated Peyote while spearheading research into its potential applications.
Our leadership team combines expertise across biotechnology, pharmaceutical manufacturing, quality assurance, marketing, and business strategy.
- Committed to sustainable cultivation practices to remove pressure on wild and sacred Peyote populations.
- Employing advanced cultivation methods to decrease the Peyote growth timeline from 13 years to as low as 3.
- Bridging traditional knowledge and modern science to better understand one of nature’s most unique botanical resources.
- Positioned to serve growing international interest in naturally derived compounds and plant-based therapeutics.